Is BASILEA PHARMACEUTIC (OTCMKTS:BPMUF) a Buy? The Stock Reported Less Sellers

September 17, 2017 - By Linda Rogers

The stock of BASILEA PHARMACEUTIC (OTCMKTS:BPMUF) registered a decrease of 4.36% in short interest. BPMUF’s total short interest was 394,600 shares in September as published by FINRA. Its down 4.36% from 412,600 shares, reported previously. With 100 shares average volume, it will take short sellers 3946 days to cover their BPMUF’s short positions.

It closed at $82.71 lastly. It is down 0.00% since September 17, 2016 and is . It has underperformed by 16.70% the S&P500.

More news for BASILEA PHARMACEUT CHF1 (REGD) (OTCMKTS:BPMUF) were recently published by: Globenewswire.com, which released: “Actelion issues invitation to 2017 Annual General Meeting of Shareholders” on March 15, 2017. Globenewswire.com‘s article titled: “CORRECTION: JOHNSON & JOHNSON TO ACQUIRE ACTELION FOR $30 BILLION WITH SPIN …” and published on January 26, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.